HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligomer Formation of Toxic and Functional Amyloid Peptides Studied with Atomistic Simulations.

Abstract
Amyloids are associated with diseases, including Alzheimer's, as well as functional roles such as storage of peptide hormones. It is still unclear what differences exist between aberrant and functional amyloids. However, it is known that soluble oligomers formed during amyloid aggregation are more toxic than the final fibrils. Here, we perform molecular dynamics simulations to study the aggregation of the amyloidpeptide Aβ25-35, associated with Alzheimer's disease, and two functional amyloid-forming tachykinin peptides: kassinin and neuromedin K. Although the three peptides have similar primary sequences, tachykinin peptides, in contrast to Aβ25-35, form nontoxic amyloids. Our simulations reveal that the charge of the C-terminus is essential to controlling the aggregation process. In particular, when the kassinin C-terminus is not amidated, the aggregation kinetics decreases considerably. In addition, we observe that the monomeric peptides in extended conformations aggregate faster than those in collapsed hairpin-like conformations.
AuthorsMartín Carballo-Pacheco, Ahmed E Ismail, Birgit Strodel
JournalThe journal of physical chemistry. B (J Phys Chem B) Vol. 119 Issue 30 Pg. 9696-705 (Jul 30 2015) ISSN: 1520-5207 [Electronic] United States
PMID26130191 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Kassinin
  • Neurokinin B
Topics
  • Amino Acid Sequence
  • Amyloid beta-Peptides (chemistry)
  • Kassinin (chemistry)
  • Molecular Dynamics Simulation
  • Molecular Sequence Data
  • Neurokinin B (chemistry)
  • Protein Multimerization
  • Protein Structure, Secondary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: